S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Atara BiotherapeuticsKrystal BiotechForma TherapeuticsCellectisInhibrx
SymbolNASDAQ:ATRANASDAQ:KRYSNASDAQ:FMTXNASDAQ:CLLSNASDAQ:INBX
Price Information
Current Price$15.96$83.63$36.40$20.11$28.95
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.61.31.81.01.5
Analysis Score4.42.53.52.22.5
Community Score2.82.53.02.93.3
Dividend Score0.00.00.00.00.0
Ownership Score0.01.71.70.00.8
Earnings & Valuation Score0.60.00.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$35.88$101.00$61.33$24.25$34.67
% Upside from Price Target124.78% upside20.77% upside68.50% upside20.59% upside19.75% upside
Trade Information
Market Cap$1.32 billion$1.66 billion$1.63 billion$941.49 million$1.12 billion
Beta2.651.2N/A2.59N/A
Average Volume865,220169,911390,044443,501174,114
Sales & Book Value
Annual RevenueN/AN/A$100.56 million$22.99 millionN/A
Price / SalesN/AN/A14.9037.16N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.37 per share$11.72 per shareN/A$8.37 per shareN/A
Price / BookN/AN/A∞2.40N/A
Profitability
Net Income$-290,980,000.00$-19,090,000.00$-34,790,000.00$-102,090,000.00N/A
EPS($5.67)($1.20)N/A($2.41)N/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-110.52%N/A
Return on Equity (ROE)-94.86%-10.72%-29.54%-23.56%N/A
Return on Assets (ROA)-82.17%-10.40%-20.61%-16.69%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.10%0.18%
Current Ratio9.41%39.96%13.55%6.11%3.80%
Quick Ratio9.41%39.96%13.55%6.00%3.80%
Ownership Information
Institutional Ownership PercentageN/A73.05%67.28%33.30%36.63%
Insider Ownership Percentage4.30%27.40%N/A16.41%N/A
Miscellaneous
Employees429518925375
Shares Outstanding77.71 million19.71 million41.16 million42.49 million37.71 million
Next Earnings Date5/5/2021 (Estimated)5/3/2021 (Estimated)3/4/2021 (Estimated)3/4/2021 (Confirmed)3/5/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.